Resource Center
Find the latest content and resources from our team of experts to keep you in the know for all things quality and regulatory in the life science industry.
Sort by topic
Sort by resource type
A Warning Letter is issued when the FDA identifies significant violations that have not been adequately addressed ...
The U.S. Food and Drug Administration has approved the first generic omeprazole oral paste for the treatment and ...
AI systems are being used to support critical decisions, including patient selection in clinical trials, ...
BIOSECURE Act is expected to significantly impact how pharmaceutical and biotechnology companies source materials, ...
Regulatory inspections are evolving as the U.S.Food and Drug Administration (FDA) expands its use of unannounced ...
Data governance refers to the framework of policies, processes, and controls used to ensure that data is accurate, ...
Corrective and Preventive Action (CAPA) is one of the most critical components of a quality management system in ...
Data integrity refers to the accuracy, consistency, and reliability of data throughout its lifecycle. In regulated ...
Interest in microbiome-based therapies continues to accelerate across global life sciences markets. As scientific ...
FDA Warning Letters are among the most significant regulatory signals an organization can receive. Issued when the ...
The U.S. Food and Drug Administration (FDA) has released new draft guidance clarifying how sponsors can qualify ...
Regulatory inspections are a routine and essential part of operating in highly regulated industries. For ...
No results found.